指南与共识胃肠动力与功能性疾病

AGA临床实践更新:嗳气、腹胀与腹部膨隆的评估和管理:专家综述

AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review.
指南 / 共识 · Gastroenterology · 2023-07-13

美国胃肠病协会(AGA)发布临床实践更新,针对嗳气、腹胀和腹部膨隆的临床特征、诊断及管理提供15条最佳实践建议,涵盖饮食、脑肠行为及药物治疗,建议基于对照试验、观察性数据和专家意见,未进行系统评价,无正式证据质量或推荐强度评级。

要点

  • 阻抗pH监测有助于区分胃源性嗳气与嗳气过强。
  • 腹胀和腹部膨隆诊断应使用罗马IV标准。
  • 益生菌不应使用于治疗腹部腹胀和膨隆。

核心结论

  • 本AGA临床实践更新为嗳气、腹胀和腹部膨隆的评估和管理提供最佳实践建议。
  • 建议基于对照试验、较稳健的观察性研究和专家意见,未进行系统评价,无正式评级。

研究设计与样本

  • 由AGA研究所临床实践更新委员会和AGA理事会委托并批准,经内部同行评议和《Gastroenterology》标准外部同行评议。
  • 建议来自已发表文献综述,包括临床试验、较稳健的观察性研究和专家意见,未进行系统评价。

主要发现

  • 临床病史、体格检查发现和阻抗pH监测可帮助区分胃源性嗳气与嗳气过强。
  • 嗳气过强的治疗选择可包括脑肠行为疗法,单独或联合使用,如认知行为疗法、膈肌呼吸、言语治疗和中枢神经调节剂。
  • 腹胀和腹部膨隆诊断应使用罗马IV标准。
  • 碳水化合物酶缺乏可通过饮食限制和/或呼气试验排除;在少数高危患者中,小肠抽吸和葡萄糖或乳果糖氢呼气试验可用于评估小肠细菌过度生长。
  • 血清学检测可排除乳糜泻,若血清学阳性应行小肠活检确诊;胃肠病学营养师应参与乳糜泻和非乳糜泻麸质敏感患者的多学科诊疗。

关键数值与推荐

  • 最佳实践建议1:临床病史、体格检查发现和阻抗pH监测可帮助区分胃源性和嗳气过强。
  • 最佳实践建议2:嗳气过强的治疗选择可包括脑肠行为疗法,单独或联合使用,如认知行为疗法、膈肌呼吸、言语治疗和中枢神经调节剂。
  • 最佳实践建议3:腹胀和腹部膨隆诊断应使用罗马IV标准。
  • 最佳实践建议4:碳水化合物酶缺乏可通过饮食限制和/或呼气试验排除;在少数高危患者中,小肠抽吸和葡萄糖或乳果糖氢呼气试验可用于评估小肠细菌过度生长。
  • 最佳实践建议5:血清学检测可排除乳糜泻,若血清学阳性应行小肠活检确诊;胃肠病学营养师应参与乳糜泻和非乳糜泻麸质敏感患者的多学科诊疗。

临床怎么用

  • 仅对警报特征、近期症状恶化或体格检查异常的患者应安排腹部影像学检查和上消化道内镜。
  • 腹胀和腹部膨隆不应常规安排胃排空检查,但若存在恶心和呕吐可考虑;除非存在其他额外且难治性下消化道症状需检查神经肌病,不应安排全肠道动力和放射不透性传输检查。
  • 对于腹胀和腹部膨隆被认为与便秘或排便困难相关的患者,建议(弱推荐)行肛门直肠生理学检查以排除盆底疾病。
  • 需要饮食调整时(如低可发酵寡糖、二糖、单糖和多元醇饮食),最好由胃肠病学营养师监测治疗;益生菌不应用于治疗腹部腹胀和膨隆。
  • 当识别出盆底疾病时,生物反馈治疗可能对腹胀和腹部膨隆有效;中枢神经调节剂(如抗抑郁药)通过降低内脏高敏感、提高感觉阈值和改善心理共病来治疗腹胀和腹部膨隆。

局限性

  • 未进行系统评价,最佳实践建议未携带关于证据质量或推荐强度的正式评级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

DESCRIPTION: Belching, bloating, and abdominal distention are all highly prevalent gastrointestinal symptoms and account for some of the most common reasons for patient visits to outpatient gastroenterology practices. These symptoms are often debilitating, affecting patients' quality of life, and contributing to work absenteeism. Belching and bloating differ in their pathophysiology, diagnosis, and management, and there is limited evidence available for their various treatments. Therefore, the purpose of this American Gastroenterological Association (AGA) Clinical Practice Update is to provide best practice advice based on both controlled trials and observational data for clinicians covering clinical features, diagnostics, and management considerations that include dietary, gut-directed behavioral, and drug therapies. METHODS: This Expert Review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review by the Clinical Practice Updates Committee and external peer review through standard procedures of Gastroenterology. These best practice advice statements were drawn from a review of the published literature based on clinical trials, the more robust observational studies, and from expert opinion. Because systematic reviews were not performed, these best practice advice statements do not carry formal ratings regarding the quality of evidence or strength of the presented considerations. Best Practice Advice Statements BEST PRACTICE ADVICE 1: Clinical history and physical examination findings and impedance pH monitoring can help to differentiate between gastric and supragastric belching. BEST PRACTICE ADVICE 2: Treatment options for supragastric belching may include brain-gut behavioral therapies, either separately or in combination, such as cognitive behavioral therapy, diaphragmatic breathing, speech therapy, and central neuromodulators. BEST PRACTICE ADVICE 3: Rome IV criteria should be used to diagnose primary abdominal bloating and distention. BEST PRACTICE ADVICE 4: Carbohydrate enzyme deficiencies may be ruled out with dietary restriction and/or breath testing. In a small subset of at-risk patients, small bowel aspiration and glucose- or lactulose-based hydrogen breath testing may be used to evaluate for small intestinal bacterial overgrowth. BEST PRACTICE ADVICE 5: Serologic testing may rule out celiac disease in patients with bloating and, if serologies are positive, a small bowel biopsy should be done to confirm the diagnosis. A gastroenterology dietitian should be part of the multidisciplinary approach to care for patients with celiac disease and nonceliac gluten sensitivity. BEST PRACTICE ADVICE 6: Abdominal imaging and upper endoscopy should be ordered in patients with alarm features, recent worsening symptoms, or an abnormal physical examination only. BEST PRACTICE ADVICE 7: Gastric emptying studies should not be ordered routinely for bloating and distention, but may be considered if nausea and vomiting are present. Whole gut motility and radiopaque transit studies should not be ordered unless other additional and treatment-refractory lower gastrointestinal symptoms exist to warrant testing for neuromyopathic disorders. BEST PRACTICE ADVICE 8: In patients with abdominal bloating and distention thought to be related to constipation or difficult evacuation, anorectal physiology testing is suggested to rule out a pelvic floor disorder. BEST PRACTICE ADVICE 9: When dietary modifications are needed (eg, low-fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet), a gastroenterology dietitian should preferably monitor treatment. BEST PRACTICE ADVICE 10: Probiotics should not be used to treat abdominal bloating and distention. BEST PRACTICE ADVICE 11: Biofeedback therapy may be effective for bloating and distention when a pelvic floor disorder is identified. BEST PRACTICE ADVICE 12: Central neuromodulators (eg, antidepressants) are used to treat bloating and abdominal distention by reducing visceral hypersensitivity, raising sensation threshold, and improving psychological comorbidities. BEST PRACTICE ADVICE 13: Medications used to treat constipation should be considered for treating bloating if constipation symptoms are present. BEST PRACTICE ADVICE 14: Psychological therapies, such as hypnotherapy, cognitive behavioral therapy, and other brain-gut behavior therapies may be used to treat patients with bloating and distention. BEST PRACTICE 15: Diaphragmatic breathing and central neuromodulators are used to treat abdominophrenic dyssynergia.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Moshiree B, Drossman D, Shaukat A, et al. AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating, and Distention: Expert Review. Gastroenterology. 2023. PMID: 37452811. doi:10.1053/j.gastro.2023.04.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。